Uncategorized
Imprimis reports $19 million net loss in 2016
Imprimis Pharmaceuticals reported a net loss of $19 million, or $1.50 per common share, in 2016 compared with a net loss of $15.9 million, or $1.66 per common share, in 2015, according to a company press release.Total revenue for the year was up 105% from 2015 to $19.9 million, and ophthalmology-related sales were up 200% to $11 million.